Decheng Capital China Life Sciences USD Fund III, L.P. sold BYSI
June 18, 2025 · Form 4 insider transaction
Decheng Capital China Life Sciences USD Fund III, L.P. sold 59,253 shares of BeyondSpring Inc. at $3.17 per share, a transaction worth $187.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 54 days after the transaction.
Footnotes
The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $3.10 to $3.34 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.; These securities are held directly by Decheng Capital China Life Sciences USD Fund II, L.P. ("Fund II"). Decheng Capital Management II (Cayman), LLC ("GP II") is the general partner of Fund II. Dr. Cui is the manager of GP II. Each of Fund II, GP II and Dr. Cui may be deemed to beneficially own the securities held by Fund II. Each of GP II and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein.